文摘
A scaleable synthetic route to [4,7']bis-isoquinolinyl-1-yl-(2-tert-butyl-pyrimidine-5-yl)amine (1), an inhibitor of B-Raf kinaseis described. The key step in the synthesis is the Pd-catalyzedNegishi coupling of 4-bromo-1-chloroisoquinoline with trifluoromethanesulfonic acid isoquinoline-7-yl ester to yield 1-chloro[4,7']bis-isoquinolinyl. This intermediate is transformed to thedesired drug substance in one additional step, by reaction with2-tert-butyl-5-aminopyrimidine in the presence of NaH. Aspecial focus was put on the finally successful removal of tracesof Zn and Pd in the drug substance, which came from theNegishi coupling.